Want to see GB:IDHC full AI Analyst Report?
IDHC Stock Chart & Stats
$0.53
$0.00(0.00%)
At close: 4:00 PM EDT
$0.53
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.36 - $0.84
Previous CloseN/A
Volume192.12K
Average Volume (3M)148.95K
Market Cap
$319.73M
Enterprise Value$199.41
Total Cash (Recent Filing)$2.13B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)11.7
Beta0.98
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.64%
Share Statistics
EPS (TTM)2.40
Shares Outstanding581,326,300
10 Day Avg. Volume181,236
30 Day Avg. Volume148,946
Financial Highlights & Ratios
PEG Ratio0.85
Price to Book (P/B)6.10
Price to Sales (P/S)2.63
P/FCF Ratio14.92
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.73
Revenue Forecast (FY)$9.82B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue MomentumAccelerating topline growth (+16.1% in 2025) indicates durable demand and scale expansion in diagnostics. Persistent revenue momentum supports reinvestment in capacity, pricing power and network effects over the coming 2–6 months, underpinning operating leverage and strategic initiatives.
High Operating ProfitabilityRobust operating margins (EBIT ~29.6%, EBITDA ~36.8%) and a healthy net margin (~16.1%) demonstrate structural cost efficiency in core diagnostics. Such margin levels support durable cash generation and funding for capex or M&A, providing resilience through moderate revenue or cost cycles.
Manageable Leverage With Strong ROEImproving leverage (debt/equity ~0.48) alongside very strong ROE (~37.3%) signals effective capital deployment. This balance between prudent leverage and high returns helps sustain growth investments and shareholder returns while preserving flexibility in financing decisions over the medium term.
Bears Say
Rising Absolute Debt LevelsAbsolute debt increases, even with improved ratios, can erode financial flexibility if earnings falter or rates stay high. Higher nominal interest exposure raises refinancing and covenant risk and may constrain strategic choices like acquisitions or elevated capex over the next several quarters.
Uneven Cash ConversionInconsistent FCF conversion (73% of net income in 2025 and a negative FCF year in 2022) points to working-capital or investment volatility. This undermines predictability of internal funding for growth, dividends or debt repayment and raises the need for external financing under stress.
Margin Softening Vs Prior PeaksEvidence of margin compression versus earlier peak years and a recent net margin decline suggests structural cost pressure or adverse mix shifts. Persistent margin headwinds would limit free cash flow expansion and reduce the cushion for cyclical downturns over the medium term.
Integrated Diagnostics Holdings News
IDHC FAQ
What was Integrated Diagnostics Holdings PLC’s price range in the past 12 months?
Integrated Diagnostics Holdings PLC lowest share price was $0.36 and its highest was $0.83 in the past 12 months.
What is Integrated Diagnostics Holdings PLC’s market cap?
Integrated Diagnostics Holdings PLC’s market cap is $319.73M.
When is Integrated Diagnostics Holdings PLC’s upcoming earnings report date?
Integrated Diagnostics Holdings PLC’s upcoming earnings report date is Aug 27, 2026 which is in 20 days.
How were Integrated Diagnostics Holdings PLC’s earnings last quarter?
Currently, no data Available
Is Integrated Diagnostics Holdings PLC overvalued?
According to Wall Street analysts Integrated Diagnostics Holdings PLC’s price is currently Overvalued.
Does Integrated Diagnostics Holdings PLC pay dividends?
Integrated Diagnostics Holdings PLC pays a Notavailable dividend of $0.009 which represents an annual dividend yield of 4.64%. See more information on Integrated Diagnostics Holdings PLC dividends here
What is Integrated Diagnostics Holdings PLC’s EPS estimate?
Integrated Diagnostics Holdings PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Integrated Diagnostics Holdings PLC have?
Integrated Diagnostics Holdings PLC has 581,326,300 shares outstanding.
What happened to Integrated Diagnostics Holdings PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Integrated Diagnostics Holdings PLC?
Currently, no hedge funds are holding shares in GB:IDHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Integrated Diagnostics Holdings Stock Smart Score
Company Description
Integrated Diagnostics Holdings PLC
Integrated Diagnostics Holdings (IDHC) is a healthcare services company focused on medical diagnostics, providing laboratory testing and related diagnostic services to support disease detection, monitoring, and clinical decision-making. null
Technical Analysis
Bioventix
―
EKF Diagnostics Holdings
―
Genedrive
―
Omega Diagnostics
―
Abingdon Health PLC
―